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Abstract 
A case-control study of breast cancer was conducted in Buffalo, New 
York. Participants completed a food frequency questionnaire and donated a 
fasting blood sample before definitive workup for breast masses. Dietary 
and plasma levels of carotenoids and retinol for 83 women found to have 
breast cancer (cases) were compared to those of 113 women found to be free 
of breast cancer {controls). Low levels of plasma beta-carotene were 
associated with increased risk of breast cancer (p=0.02). There was no 
overall association between retinol and breast cancer, but a positive 
relationship between retinol and breast cancer was present in the subgroup 
with low beta-carotene values. No statistically significant associations 
were observed in the dietary data. These results suggest that dietary 
practices associated with lower plasma beta-carotene values are associated 
with increased risk of breast cancer and that plasma indicators of,· 
nutrients may be more useful than dietary indicators of nutrient status in 
studies of limited sample size. 
Key Words: Carotenoids, Vitamin A, Breast Cancer, Diet, Plasma, 
Benign Breast Disease, Epidemiology 
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Introduction 
The roles of vitamin A and carotenes in carcinogenesis have been 
investigated in a large number of experimental systems (1). Supplemental 
retinyl acetate in animal diets may cause either lower (2-8) or higher (9) 
incidence of mammary tumors, whereas supplemental beta-carotene in the 
diet has been shown to inhibit mammary tumors (10,11) and transplantable 
tumors (12). 
Epidemiological studies have indicated a negative association 
between plasma retinol and risk of cancer of all sites (13,14) with only 
suggestive evidence for this association in breast cancer (15). Two 
studies with dietary data (16,17) and three studies with plasma data {18-
20) showed no association between breast cancer and retinol, whereas one 
study using plasma {16) showed a positive association. Two other dietary 
studies (21,22) indicated a negative association between breast cancer and 
total vitamin A intake with contributions from both preformed and 
precursor (carotenes) vitamin A. 
A negative association has been observed between breast cancer and 
estimates of dietary intake of carotenes (17) and vegetables {23}. 
Although results from two plasma studies {16,19} showed no association 
between breast cancer and total carotenoids or beta-carotene, 
respectively, results from two other plasma studies (18,24) reported a 
nonsignificant negative association between breast cancer and beta-
carotene. 
Overall, previous studies indicate either no association or a direct 
association between breast cancer and retinol, and no association or a 
negative association between carotenes and breast cancer. Some studies 
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were not specifically designed to investigate breast cancer and suffered 
from inadequate power (18-20), whereas others did not control for 
important breast cancer risk factors (19-21,24) or plasma lipids (18,20, 
24). These limitations may have diminished the ability to observe the 
effects of nutrients on cancer risk. 
This case-control study was designed to assess the independent and 
interactive effects of preformed vitamin A and carotenoids, in the plasma 
and in the diet, controlling for other risk factors and other nutrients. 
Methods 
Between September 1985 and September 1986, study subjects were 
enrolled from the breast clinic at Roswell Park Memorial Institute, and 
from the offices of two private surgeons in Buffalo, New York. Eligible 
patients were women 30 to 80 years of age who were being evaluated for a 
breast mass, but who had no previous history of cancer. All participants 
had lived in upstate New York or Pennsylvania for at least one year.: 
After subjects were scheduled for a diagnostic biopsy, informed consent 
was obtained and they were given a questionnaire and directions for the 
blood collection procedure. Thirty-four patients who were referred to the 
specialists because of a suspicious mammogram or lump but were determined 
not to have masses requiring biopsy were included in the control group. 
Patients were classified into one of three groups based on tneir 
pathology reports from the breast biopsies; cases (n=83), controls (n=113) 
or excluded (n=40). Cases were women found to have breast cancer 
(IDC9=174). The 113 controls were those 79 women who were found to have 
benign lesions on biopsy, plus the 34 women who did not require a biopsy. 
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The 40 patients with biopsy reports that described lesions thought to be 
at increased risk of breast cancer (predominantly of an atypical 
hyperplastic nature) were excluded from the control group. 
The self-administered questionnaire requested information about the 
subjects' dietary practices and medical history. A food-frequency table 
with 5 frequency categories (never, rarely, 1-3x/month, 1-4x/week and 5-
7x/week) contained a list of 30 food items that previous analysis {25) 
indicated would account for 90% of the variance associated with estimated 
vitamin A intake. Standard portion sizes were assumed to convert the 
frequency data into estimates of nutrient intake. 
Fasting blood samples were drawn from subjects before their biopsies 
or on a designated day for the 34 patients without biopsies. The samples 
were centrifuged, plasma was preserved in sodium ascorbate {10 mg/ml 
plasma) and frozen at -80°C until the end of the study. Samples were 
thawed once for portioning of aliquots and once for the laboratory 
analysis. Retinol and carotenoids were analyzed by HPLC; retinol hy a 
modification (26) of a standard method (27) and carotenoids by a 
modification (26) of a new method (28). 
Statistical analyses were conducted using SYSTAT (version 3.0, 
Systat, 1985) and the supplementary logit program on an AT&T 6300 
Personal Computer. Differences in means were tested with the Student's T-
test and differences in proportions were tested using logit anal)sis. In 
the latter analyses, case status was the independent variable, the breast 
cancer risk factor was the dependent variable and other breast cancer risk 
factors were added to the model as needed. Nutrients were log-transformed 
and categorized into quartiles based on their distribution in the 
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controls. Multivariate analyses used logit analysis with case status as 
the dependent variable; there were three possible outcome categories but 
only the case versus control results are presented here. In the 
multivariate analyses, the non-nutrient breast cancer risk factors used as 
covariates were age, age at menarche, age at menopause, age at first 
birth, parity, menopausal status, family history of breast cancer in a 
first-degree relative, Quetelet index {kg/m2), marital status and income. 
Analyses of the plasma retinol and carotenoid variables also controlled 
for plasma lipids to evaluate the effect of the nutrient of interest after 
differences in lipid status were eliminated. In addition, both 
triglycerides and cholesterol were associated with case status and 
therefore were potential confounding variables. Tests for trend used the 
continuous, log-transformed nutrient variable. The models and variables 
were assessed using the log likelihood ratio test and all significant 
predictors of case status were included in the full models, as well as the 
non-nutrient breast cancer risk factors. 
Results 
The characteristics of the cases and controls at baseline are 
presented in Table 1. Cases were statistically significantly older than 
controls, but were not statistically different from controls in any of the 
other potential confounding variables. Nonetheless, many of the known 
breast cancer risk factors were not more prevalent among cases than 
controls. Therefore, these controls were at high risk for breast cancer 
according to known breast cancer risk factors. Thus, this study compared 
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women with breast cancer with a group who had similarly high risk, but who 
did not have breast cancer. 
Cases had significantly lower beta-carotene and lycopene values than 
controls (p<O.Ol and p<0.05, respectively) (Table 2), but were not 
different in the mean values for retinol, alpha-carotene or the dietary 
estimates of vitamin A intake. Multivariate analysis showed that low 
beta-carotene was associated with an increased risk of breast cancer, with 
and without adjustment for plasma lipids (Table 3). Alpha-carotene was 
not associated with breast cancer risk, perhaps because of its low 
concentration and small range (Table 2), making it difficult to assess its 
effect given the sample size in this study. In addition, the collinearity 
between beta-carotene and alpha-carotene (correlation coefficient = 0.71) 
made it difficult, if not impossible, to assess the independent alpha-
carotene effect when the full model required both carotenoid variables. 
Although low levels of lycopene appeared to be associated with increased 
risk of breast cancer before controlling for plasma lipids, lycopene was 
not associated with case status after controlling for these lipids. 
The main effect of plasma retinol values indicated no association 
with breast cancer risk (Table 3); however, a statistically significant 
interaction with plasma beta-carotene (Table 4) showed a trend of 
increasing risk for breast cancer with increasing retinol within the low 
beta-carotene quartile. The wide confidence intervals indicated·few 
individuals in the cells with increased risk; even so, the results were 
statistically significant. Although the other confidence intervals 
included unity, the trends indicated that, within the other beta-carotene 
quartiles, risk decreased as retinol increased. 
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Multivariate analyses of the dietary data indicated no association 
between breast cancer and either estimate of vitamin A intake {Table 5). 
There was no statistically significant interaction between total vitamin A 
and vegetable vitamin A. Neither of the dietary variables was correlated 
with plasma retinol, beta-carotene or lycopene values. Alpha-carotene, 
however, was marginally correlated with total vitamin A {r = 0.26). 
Discussion 
The Control Group 
The control group in this study were women at high-risk for breast 
cancer. There are two possible biases of concern with this control group. 
If factors associated with the high-risk classification were also 
associated with nutrient status, then the results may be biased towards a 
false positive or spurious finding. No evidence was found supporting an 
association between benign breast disease and any of the nutrients 
investigated, and it is unlikely that other components of the high,risk 
classification (i.e., age at menarche, age at first birth, etc.) are 
related to these nutrients. In contrast, the controls were very similar 
to the cases, which would bias the results towards a false negative 
finding of no association. This is only of concern with the 
nonsignificant alpha-carotene and lycopene findings but is not of concern 
with the significant beta-carotene and retinol findings. Indeed, the 
similarity between the groups may be a strength of the study because the 
absence of unnecessary variability may have increased the power to observe 
associations. That is, the analysis focused on the factors that allowed 
the controls to be free of cancer even though they were very similar to 
8 
the cases and at high-risk of breast cancer. A difference i·n nutritional 
status between these two groups would be of considerable interest because 
it would suggest a nutritional advantage among the controls very late in 
the promotional stages of the disease process. These results not only 
indicated such a difference existed between these groups but also that the 
difference was in the same direction (low beta-carotene, higher risk) as 
that frequently observed in earlier etiological stages. 
Plasma Beta-carotene 
The levels of carotenoids in this study were relatively low compared 
to similar groups of women in the United States (29,30). Quality control 
plasma samples were exchanged between laboratories, which determined that 
our assay yielded values approximately one-half the values obtained by 
other standard methods (31,32) due to lower extraction efficiency of the 
solvent. All carotene values are reported here in the original form 
because relative, not absolute values are required for the statistical 
analyses. 
The association of lower beta-carotene values with breast cancer may 
be confounded by alcohol intake, which was not measured in this study. 
Alcohol has been associated with breast cancer in 14 studies (33-46), but 
not in 7 other studies (47-53). In addition, alcohol may be associated 
. 
with lower plasma beta-carotene values (30, 54), although this effect has 
only been observed in men and it is unclear whether alcohol is directly 
related to lowering beta-carotene or is coincident with lower beta-
carotene intake. Further research is warranted to determine whether the 
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association of plasma beta-carotene values with breast cancer persist 
after controlling for alcohol consumption. 
lower plasma beta-carotene values in the breast cancer patients may 
also be a result rather than a precursor of disease. A marginally 
significant trend (p=0.08) of decreasing beta-carotene values with 
increasing stage of disease was observed; this suggests that the disease 
may alter this blood parameter. Alternatively, the patients with later 
stage disease may have altered their intake to a greater degree than the 
patients with earlier stage disease. Although it is unclear which 
phenomenon is present, there is some evidence against a metabolic 
alteration due to the disease. A prospective study in Britain (18) 
demonstrated that the cases diagnosed within two years of blood 
collection did not have lower beta-carotene than cases diagnosed later. 
In addition, there is no evidence from animal studies that tumors affect 
the levels of this nutrient, whereas there is evidence that low beta-
carotene intake promotes mammary tumors (10}. 
Plasma beta-carotene has been shown to reflect dietary intake of 
beta-carotene {24,55,56) and total carotene intake (30,54,57), therefore, 
the lower beta-carotene levels observed to be associated with case status 
may be of dietary origin. Although the dietary data from this study did 
not support this conclusion, results from larger dietary studies 
indicated that lower estimated intakes of total vitamin A (21) or beta-
carotene (17) were associated with breast cancer. 
There have been four other investigations of breast cancer that have 
measured plasma carotene values. In a prospective study in England (18), 
the authors found (nonsignificantly) lower plasma beta-carotene values in 
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women later diagnosed with breast cancer. Although these findings were 
later questioned because of storage considerations (58), the present study 
corroborates these findings. In a preliminary report (24), the mean 
plasma beta-carotene level of 30 women with metastatic breast cancer was 
21% lower than in controls. Willett and coworkers (19) did not find an 
association between breast cancer and plasma carotenoids; this study was 
limited by sample size (n=14 cases) and did not control for important 
confounding factors, however. In a case-control study in Italy (16), the 
authors did not find an association between breast cancer and plasma beta-
carotene values. The mean beta-carotene values were relatively high in 
this population, which suggests that there were few individuals in the 
low range where the effect was observed in the present study (even if our 
values were doubled to allow for analytical extraction efficiency). 
Plasma Retinol 
The higher risk observed with higher retinol within the low b~ta­
carotene quartile is consistent with the concept that diets with higher 
intakes of animal products and lower intakes of vegetables may increase 
breast cancer risk. These results are supported by studies that 
associated breast cancer with low dietary intake of total vitamin A (21, 
22) or beta-carotene (17) and high plasma retinol (16). Rohan and 
coworkers {17) also reported significantly increased risk of breast cancer 
with increased consumption of retinol, although the results were confined 
to premenopausal cases. The strongest univariate correlations for plasma 
retinol from a large ecological study in China (59) show that it is 
positively correlated to meat and milk consumption (r= 0.44 and 0.31, 
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p<0.001 and p<0.050, respectively) and negatively correlated with plant 
protein and legumes (r= -0.50 and -0.31, p<0.001 and p<0.050, 
respectively). However, there are several reports of no association 
between dietary vitamin A and plasma retinol (24,55-57,60). Additionally, 
retinol has been positively associated with plasma estrogens (61) and, 
because estrogens may be associated with breast cancer promotion, higher 
retinol levels may merely be a marker for the estrogenic environment or, 
perhaps, part of the mechanism by which estrogens exert their effect. 
Nonetheless, the pattern of risk observed suggests that beta-carotene is 
not acting solely through its conversion to retinol, and that these two 
nutrients may have some interdependent functions in carcinogenesis. 
Dietary Data 
The results from the dietary data were consistent with one study 
(16) that did not find an association between breast cancer and dietary 
beta-carotene. Other dietary studies (17,21,22) with larger sample:sizes 
(451, 2024 and 120 cases, respectively) than the present study did show 
associations using dietary indicators of vitamin A or beta-carotene. 
Preliminary analysis of the reproducibility of the dietary data 
suggests poor agreement in frequency categories between first and second 
questionnaires (59% exact agreement, 71% agreement plus or minus one 
. 
frequency category). Thus, these dietary data included a large amount of 
unaccounted for variability, which biased the results toward the null 
hypothesis. The positive findings using the plasma indicators, the lack 
of a correlation between the plasma and dietary indicators of vitamin A 
and the lack of reproducibility of the dietary data suggest that dietary 
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indicators were not as sensitive as plasma indicators. Therefore, a 
larger samples size would be required for the food frequency methodology 
employed here to be useful. 
Commentary 
There were two other results of methodologic importance. First, the 
lack of a main effect of plasma retinol and the presence of an interactive 
effect between plasma retinol and beta-carotene demonstrated the 
importance of investigating nutritional interactions in studies on cancer 
etiology. Second, plasma lycopene values were associated with case status 
only before the plasma lipids were controlled in the analysis, which 
demonstrated the importance of this adjustment in the analyses of lipid-
soluble nutrients. It was necessary to control for the these lipids to 
observe the independent effect of the nutrient (or lack of an effect) 
after differences in lipid-status were eliminated and the association of 
the lipid with case status was removed. Stryker et al. (30) demons~rated 
a better correlation between calorie-adjusted dietary intake of fat-
soluble nutrients (carotenoids and tocopherols) and the lipid-adjusted 
plasma levels of these nutrients compared with the unadjusted levels. 
Therefore, the inference of risk estimates from plasma data to dietary 
intake is stronger after the plasma variables have been adjusted for these 
lipids. 
The beta-carotene findings in our study are in accord with studies 
finding an association between low beta-carotene and cancers of epithelial 
origin (62). It is important to note, however, that high plasma beta-
carotene may also be a marker for carotene-rich foods so that other 
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carotenes, or other constituents of these foods, may be the·more important 
risk factors. Low plasma beta-carotene in combination with high retinol 
was found to be associated with breast cancer, which was consistent with 
diets lower in carotene-containing vegetables and higher in preformed 
vitamin A. Further research into this interaction by other investigators 
is recommended. 
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Table 1 
Descriptive statistics of potential confounding variables 
for cases and controls, breast cancer study 
Cases Controls 
Variable Mean (SD)a Mean (SO) 
(N=83) (N=ll3) 
Age (yr) 57.78 (11.01)* 50.47 {10.81) 
Weight (kg) 69.79 (13.49) 67.85 (12.00) 
Height {em) 164.75 (7.33) 165.19 (7.93) 
Quetelet index (kg/m2) 25.82 (5.16) 24.89 (4.52) 
Age at Menarche (yr) 12.83 (1. 30) 12.70 (1.57) 
Age at First Birth (yr) 23.43 (3.95) 23.37 (4.29) 
Parity 3.03 ( 1. 36) 3.36 ( 1. 63) 
Age at Menopause (yr) 47.66 {6. 27) 47.02 {5.9~} 
Months of Breastfeedingb 5.21 {9.01) 6.70 (10.47) 
(%of diagnostic grouQ} 
Menopausal 66 57 
Surgical MenopauseC 40 33 
Family Hi storyd 28 39 
Married 71 87 
Never Married 13 9 
Widowed 16 4 
Nulliparous 16 17 
15 
History of BBoe 
Two Highest Income Groupsf 
29 
29 
a Abbreviations used; BBD = benign breast disease, 
SO = standard deviation. 
b Total months in lifetime spent breastfeeding. 
c Percent of those who were menopausal. 
d Family history of breast cancer 
40 
42 
e Self-reported history of a previous diagnosis of BBD. 
f Two highest of 7 income categories 
* Significantly different (p<O.OOl) from controls. 
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Table 2 
Comparison of plasma and dietary variables 
among cases and controls, breast cancer study 
Variable 
Plasma: 
Retinol (mg/dl) 
Beta-carotene (ug/dl) 
Alpha-carotene (ug/dl) 
Lycopene (ugjdl) 
Diet: 
Total Vitamin A (IU/day) 
Cases 
(N=81) 
55.98 (17.72)a 
11.20 (8.62) 
3.06 (2.18) 
22.36 (10.11) 
11,900 (6,800) 
Vegetable Vitamin A (IU/day) 1,770 (2,400) 
a Mean (standard deviation) 
**Significantly (p<0.01) different from cases 
* Significantly (p<0.05) different from cases 
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Controls 
(N=101) 
55.23 (12.66) 
13.75 (8.02)** 
3.44 (1.99) 
26.38 (12.76)* 
12,300 (6,800) 
1,900 (2,900) 
Table 3 
Case versus control odds ratios for plasma nutrient 
quartiles with adjustments for potential confounding variable~ 
with and without lipid adjustmentb, breast cancer study 
Quart il es 
Low High Trend 
Nutrient Q1 Q2 Q3 Q4 p-value 
Lipid-unadjusted: 
Beta-carotene 4.42c 1. 90 1.41 1.00 <0.01 
( 1. 33' 14. 7) d (0.55,6.55) (0.43,4.64) 
Alpha-carotene 2.69 1.12 0.96 1.00 0.18 
(0.88,8.23) (0.36,3.51) (0.31,2.99) 
Lycopene 2.40 2.45 1.55 1.00 0.09 
(0.83,6.95) (0.87,6.93) (0.51,4.72) 
Retinol 1.11 1. 21 0.64 1.00 0.67 
. 
(0.38,3.26) (0.41,3.55) (0.23,1.83) 
-· 
Lipid-adjusted: 
Beta-carotene 3.15 1. 79 1.18 1.00 0.02 
( 0. 90, 11.04) (0.50,6.39) (0.34,4.09) 
Alpha-carotenee 0.63 0.45 0.61 1.00 0.19 
(0.13,2.95) ( 0 . 11 ' 1. 80) (0.18,2.06) 
Lycopene 1.60 1. 94 1.39 1.00 0.43 
(0.50,5.18) (0.64,5.88) (0.45,4.32) 
Retinole 1.06 1.01 0.60 1.00 0.41 
(0.31,3.64) {0.32,3.25) (0.18,1.97) 
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a Adjusted for age, age at first birth, family history, age at menarche, 
Quetelet index, parity, age at menopause, income and marital status. 
b Lipids include plasma cholesterol and triglyceride 
c Odds ratio of quartile compared with the fourth quartile 
d 95% confidence limits 
e Full model also contained beta-carotene 
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Table 4 
Case-control adjusteda odds ratios for the retinol by 
beta-carotene interaction, breast cancer study 
Odds Ratios (CI} 
Retinol Beta-carotene guartiles 
Level low High 
(percentile) b Q1 Q2 Q3 Q4 
Lowe (25) 3.41 4.07 3.64 3.85 
(0.75,15.6) (0.90,18.5) (0.66,20.1) (0.84,17.6) 
[9/7]d [5/5] [5/3] [ 4/4] 
Median (50) 5.50 2.90 1.92 1.92 
(1.30,23.2) (0.71,11.9) (0.45,8.21) (0.92,4.00) 
[14/14] [9/14] [9/14] [4/10] 
High (75) 8.58 2.11 1.06 l:ooe 
( 1. 82' 40. 5) (0.48,9.30) (0.23,4.91) 
[12/4] [3/6] [4/8] [3/8] 
a Adjusted for cholesterol, triglyceride, beta-carotene, the 
retinol by beta-carotene interaction, age, age at first birth, 
family history, age at menarche, Quetelet index, pari~y, 
age at menopause, income and marital status. 
b Percentile based on ranking of all study subjects 
c Low=43.6 ug/dl, Median=52.6 ug/dl, High=62.7 ug/dl 
d Number cases/controls 
e Reference group 
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Table 5 
Case versus control odds ratios for dietary nutrient 
quartiles with adjustments for potential confounding variables 
in the full modela, breast cancer study 
Quartiles 
Low High Trend 
Nutrient Ql Q2 Q3 Q4b p-value 
Total 1.35c 1.43 0.45 1.00 0.56 
Vitamin A (0.50,3.60)d (0. 53,3 .87) ( 0 • 14' 1. 45) 
Vegetable 1.27 1.72 1.48 1.00 0.52 
Vitamin A (0.44,3.67) (0.66,4.48) (0.50,4.36) 
a Adjusted for age, age at first birth, family hi story, menarche, 
Quetelet index, parity, age at menopause, income and marital status. 
b Reference group 
c Odds ratio of quartile compared with the fourth quartile 
d 95% confidence limits 
21 
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